ممکن است صدای این قسمت خراب باشد.
How to fix it?
درباره این اپیزود
Critical Care Reviews’ Rob Mac Sweeney talks with Prof. Alistair Nichol about ivermectin, one of the latest interventions added to the REMAP-CAP trial. He explains why this intervention is implemented into the trial despite the controversy surrounding the use of ivermectin to treat COVID-19.
انگلیسی
ایالات متحده آمریکا
جستجوی اپیزودهای گذشته
اپیزودهای قبلی REMAP-CAP را جستجو کن.
قسمت های دیگر در این پادکست
Critical Care Reviews’ Rob Mac Sweeney talks with professor Mathias Pletz about pandemics and the COVID-19 pandemic mode of REMAP-CAP.
Critical Care Reviews’ Rob Mac Sweeney talks with professor Steve Webb about the design of REMAP-CAP. In this episode we describe the rationale behind the trial and its origin.
Critical Care Reviews’ Rob Mac Sweeney talks with professor John Marshall and assistant professor Srinivas Murthy about the interventions in REMAP-CAP.
Critical Care Reviews’ Rob Mac Sweeney talks with Dr. Scott Berry about the statistical plan of REMAP-CAP.
Together with Derek Angus and Tony Gordon, Rob Mac Sweeney dives into the first results of the REMAP-CAP trial and the launch of the first manuscript in JAMA. In this episode we discuss the methodology of the trial and the results of this manuscript.
سلب مسئولیت: پادکست و آثار هنری تعبیه شده در این صفحه متعلق به REMAP-CAP است که متعلق به صاحب آن است و به Listen Notes، Inc وابسته یا تایید نشده است.
ویرایش
از کمک شما برای بروز نگهداشتن پایگاهدادههای پادکست سپاسگزاریم
